XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.65

-0.8%

Jan 23 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (9426)	3/30/1999 12:27:00 AM
From: aknahow	Read Replies (2) of 17367

Jan. 7 1999 press release. <In April 1996, as part of its long-term partnering strategy, Genentech entered into a collaboration agreement with XOMA to develop Genentech's hu1124 molecule through Phase II. This part of the collaboration is now complete, and based on the Phase II results Genentech will decide early in 1999 whether to continue the product collaboration with XOMA or itself continue with Phase III development. XOMA may decide whether to receive payments from Genentech when the molecule is commercialized or participate with Genentech in profit-sharing from the ultimate sales of the product.> The info. you found was dated Feb. 17. I cannot believe that it would be Martin's idea of a smart move to hold news on an agreement with Genetech back. I am beginning to understand Bluebeard's anger!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next